BioMarin's Agenda Includes $4bn In Sales And Business Development
The company laid out a growth strategy to investors centered on three business units, $4bn in revenue by 2027 and $500m in cost savings.
The company laid out a growth strategy to investors centered on three business units, $4bn in revenue by 2027 and $500m in cost savings.